| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-116084 |
Trimethylamine N-oxide |
Activator |
98.0% |
Unkown |
| HY-126675A |
AS2863619 |
|
98.02% |
Unkown |
| HY-100830 |
NCB-0846 |
Inhibitor |
99.61% |
Unkown |
| HY-108915 |
Trimethylamine N-oxide dihydrate |
Activator |
99.86% |
Unkown |
| HY-116084S |
Trimethylamine N-oxide-d9 |
Activator |
99.76% |
Unkown |
| HY-124447 |
BTYNB |
|
98.0% |
Unkown |
| HY-N6985 |
Baccatin III |
|
99.82% |
Unkown |
| HY-N2037A |
Higenamine hydrochloride |
|
99.34% |
Unkown |
| HY-N6013 |
Aloin (mixture of A&B) |
|
99.36% |
Unkown |
| HY-132187 |
Sphingosylphosphorylcholine |
|
99.50% |
Unkown |
| HY-N3266 |
Methyl rosmarinate |
|
99.89% |
Unkown |
| HY-100448A |
Butaprost |
|
99.85% |
Unkown |
| HY-126675 |
AS2863619 free base |
|
99.87% |
Unkown |
| HY-100444 |
SIS3 free base |
Inhibitor |
98.02% |
Unkown |
| HY-144043 |
ALK5-IN-8 |
Inhibitor |
98.21% |
Unkown |
| HY-P5542 |
Vicatertide |
Inhibitor |
99.24% |
Unkown |
| HY-18766 |
EW-7195 |
Inhibitor |
98.84% |
Unkown |
| HY-122856 |
AZ12601011 |
Inhibitor |
99.78% |
Unkown |
| HY-123900 |
AZ12799734 |
Inhibitor |
98.67% |
Unkown |
| HY-N0363 |
(+)-Columbianetin |
|
99.04% |
Unkown |
| HY-N4107 |
Phyllanthin |
Inhibitor |
99.97% |
Unkown |
| HY-P10414A |
Klotho-derived peptide 1 hydrochloride |
Inhibitor |
99.67% |
Unkown |
| HY-118528A |
TP0427736 hydrochloride |
Inhibitor |
99.91% |
Unkown |
| HY-N0363A |
(+)-Columbianetin acetate |
|
99.83% |
Unkown |
| HY-P10363 |
Tiger17 |
Activator |
98.47% |
Unkown |
| HY-100830A |
NCB-0970 |
Control |
98.81% |
Unkown |
| HY-171878 |
BI-4659 |
Inhibitor |
99.78% |
Unkown |
| HY-P11223 |
CMF9 |
Inhibitor |
98.65% |
Unkown |
| HY-RS13393 |
SMAD2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-117511 |
HJC0123 |
|
99.06% |
Unkown |
| HY-161398 |
TGFβRII-IN-3 |
|
99.51% |
Unkown |
| HY-183067 |
TAS1440 |
|
/ |
Unkown |
| HY-P10359A |
TAT-QFNP12 acetate |
Inhibitor |
95.90% |
Unkown |
| HY-P4890A |
Relaxin H3 (human) TFA |
|
/ |
Unkown |
| HY-RS17208 |
Smad2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-116084S1 |
Trimethylamine-N-oxide-13C3 |
Activator |
/ |
Unkown |
| HY-10321G |
PD173074 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-107614G |
1-Oleoyl lysophosphatidic acid sodium (GMP) |
Activator |
/ |
Unkown |
| HY-120973 |
Butaprost free acid |
|
/ |
Unkown |
| HY-126675G |
AS2863619 (GMP) |
|
/ |
Unkown |
| HY-162404 |
(14S,15R)-14-Deoxyoxacyclododecindione |
Inhibitor |
/ |
Unkown |
| HY-162405 |
STAT6-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-168607 |
ALK5-IN-83 |
Inhibitor |
/ |
Unkown |
| HY-170578 |
SIRT2-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-172108 |
TGFβRI-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-181430 |
PXS 25 |
Inhibitor |
/ |
Unkown |
| HY-181431 |
PXS 64 |
Inducer |
/ |
Unkown |
| HY-183067A |
TAS1440 benzoate |
|
/ |
Unkown |
| HY-P10359 |
TAT-QFNP12 |
Inhibitor |
/ |
Unkown |
| HY-P10414 |
Klotho-derived peptide 1 |
Inhibitor |
/ |
Unkown |
| HY-P11827 |
C11 peptide-1 |
Inhibitor |
/ |
Unkown |
| HY-P4890 |
Relaxin H3 (human) |
|
/ |
Unkown |
| HY-W108953 |
Myristoyl tetrapeptide-12 |
Activator |
/ |
Unkown |
| HY-W722562 |
Trimethylamine oxide-15N |
|
99.93% |
Unkown |
| HY-Y1269D |
Ammonium chloride, for molecular biology |
|
/ |
Unkown |
| HY-118528 |
TP0427736 |
Inhibitor |
/ |
Unkown |
| HY-12273G |
DMH-1 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-124595 |
MPT0B098 |
Inhibitor |
/ |
Unkown |
| HY-N0363AR |
(+)-Columbianetin acetate (Standard) |
|
/ |
Unkown |
| HY-N0363R |
(+)-Columbianetin (Standard) |
|
/ |
Unkown |
| HY-N2037AS1 |
Higenamine-d4-1 hydrochloride |
|
/ |
Unkown |
| HY-N6013R |
Aloin (mixture of A&B) (Standard) |
|
/ |
Unkown |
| HY-RS23660 |
Smad2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |